Recall: D-0493-2017

Class II - Potentially Harmful

Class IIClassification

2017-01-27Initiated

TerminatedStatus

Mylan Institutional, Inc. (d.bFirm

Product

Mirtazapine Tablets, USP, 45 mg. Rx only, 100 Tablets (10 X 10). Manufactured by: Mylan Pharmaceuticals Inc, Morgantown, WV ---NDC 51079-088-20

Reason

Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablets commingled

Distribution

Nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.